Email this article CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism
- Authors: Zhaldak DA1, Melekhovets OK1, Orlovskyi VF1
-
Affiliations:
- Сумской государственный университет МОН Украины
- Issue: Vol 89, No 10 (2017)
- Pages: 62-65
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32322
- DOI: https://doi.org/10.17116/terarkh2017891062-65
- ID: 32322
Cite item
Full Text
Abstract
Aim. To investigate the association of the polymorphic variants -204A > C (rs 3808607) in the CYP7A1 gene with the development of dyslipidemias in healthy individuals, in patients with non-alcoholic fatty liver disease (NAFLD) and in those with NAFLD concurrent with hypothyroidism. Subjects and methods. DNA samples and lipidograms were examined in 180 patients, including 60 healthy individuals (Group 1), 60 patients with hypothyroidism concurrent with NAFLD (Group 2), and 60 patients with NAFLD (Group 3). All the patients underwent ultrasound examination of the thyroid gland and abdominal cavity organs; FibroMax scores were calculated. Results. All the study groups most frequently showed a homozygous AA genotype (86.6% of cases in Group 1, 80% in Group 2, and 83.3% in Group 3). The development of NAFLD in CC genotype carriers is characterized by the most pronounced changes in lipid metabolism (atherogenic index (AI), 7.32 in Group 3) compared to the genotypes AA (AI, 4.56 in Group 2 and 1.73 in Group 1) and CC (AI, 6.43 in Group 2 and 2.52 in Group 1) in functional insufficiency of thyroid hormones and relative normal conditions. Conclusion. The analysis of the relationship of polymorphic variants CYP7A1 rs 38088607 to lipid metabolic disturbances in the study groups showed that the significantly higher levels of atherogenic cholesterol fractions were determined in the CC genotype compared to AA genotype carriers and they did not depend on the presence of NAFLD and hypothyroidism. The findings make it possible to consider the AA homozygous genotype of variant mutation CYP7A1 rs 38088607 as protective against dyslipidemia. However, in functional insufficiency of thyroid hormones, the level of triglycerides is significantly higher in both genotypes, which suggests that hypothyroidism plays an essential role in the development of dyslipidemia and NAFLD.
Full Text
##article.viewOnOriginalSite##About the authors
D A Zhaldak
Сумской государственный университет МОН УкраиныСумы, Украина
O K Melekhovets
Сумской государственный университет МОН УкраиныСумы, Украина
V F Orlovskyi
Сумской государственный университет МОН УкраиныСумы, Украина
References
- Петухов В.А. Липидный дистресс — синдром: диагностика и методы лечения. М: ВЕДИ; 2003:88.
- Руководство по кардиологи. Под ред. Коваленко В.Н. Киев: МОРИОН; 2008:184-221.
- Поликлиническая терапия. Под ред. Галкина В.А. Издательство Медицина; 2000:51-58.
- Кравчун Н.А., Чернявская И.В. Гипотиреоз: эпидемиология, диагностика, опыт лечения. Проблемы эндокринной патологи. 2011;3:27-34.
- Подзолков А.В., Фадеев В.В. Высоко- и низконормальный уровень ТТГ: клиническая картина, психоэмоциональная сфера и качество жизни пациентов с гипотиреозом. Клиническая и экспериментальная тиреоидология. 2010;6(4):58-68. https://doi.org/10.14341/ket20106458-68
- Фадеев В.В. Современные принципы диагностики и лечения гипотиреоза. Земский врач. 2010;2:20-26.
- Muls E., Kolanowski J. Et al. The effects of orlistat on weight and serum lipids in obese patients with hypercholesterolemia: A randomized, double-blind, placebo controlled multicentre study. International Journal of Obesity. 2001:25(11):1713-1721. https://doi.org/10.1038/sj.ijo.0801814
- Qiang Cai et. al. Relationship between CYP7A1 -204A>C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis. Lipid in Health and Disease. 2014:13:126. https://doi.org/10.1186/1476-511X-13-126
- De Castro-Oros I., Pampin S., Cofan M. Et. Al. Promoter variant -204A > C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity intransfected HepG2 cells. Clinical Nutrition. 2011;30(2):239-246. https://doi.org/10.1016/j.clnu.2010.07.020
- Couture P, Otvos JD, Cupples LA et al. Association of the A-204C polymorphism in the cholesterol 7α-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. Journal of lipid research. 1999;40:1883-1889.
- Ивашкин В.Т., Драпкина О.М. Диагностика и лечение неалкогольной жировой болезни печени (методические рекомендации). М.: ООО «Издательский дом «М-Вести». 2012:20.
- Ratziu V, Massard J, Charlotte F et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:6. https://doi.org/10.1186/1471-230X-6-6
- Sanal MG. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes? World J. Gastroenterol. 2015;21(11):3223-3231. https://doi.org/10.3748/wjg.v21.i11.3223
- Mounia Qrafi, Youssef Amar, Jamaleddine Bourkadi et al. The CYP7A1 gene rs 3808607 variant is associated with susceptibility of tuberculosis in Moroccan population. The Pan African Medical Journal. 2014;18:1. https://doi.org/10.11604/pamj.2014.18.1.3397
